Utilize este identificador para referenciar este registo: https://hdl.handle.net/10316/4706
Campo DCValorIdioma
dc.contributor.authorReis, F.-
dc.contributor.authorLemos, E. Teixeira de-
dc.contributor.authorAlmeida, L.-
dc.contributor.authorParada, B.-
dc.contributor.authorGarrido, A. P.-
dc.contributor.authorRocha-Pereira, P.-
dc.contributor.authorSantos-Silva, A.-
dc.contributor.authorSantos-Dias, J.-
dc.contributor.authorDinis, A.-
dc.contributor.authorFigueiredo, A.-
dc.contributor.authorCosta-Almeida, C.-
dc.contributor.authorMota, A.-
dc.contributor.authorTeixeira, F.-
dc.date.accessioned2008-09-01T14:13:04Z-
dc.date.available2008-09-01T14:13:04Z-
dc.date.issued2007en_US
dc.identifier.citationTransplantation Proceedings. 39:8 (2007) 2501-2506en_US
dc.identifier.urihttps://hdl.handle.net/10316/4706-
dc.description.abstractThe present study sought to evaluate the prevention and reversion effects of isosorbide-5-mononitrate (Is-5-Mn) on the development of hypertension (HT) and on the underlying vascular and platelet morphofunctional disturbances, using an animal model of cyclosporine (CsA)-induced HT. The following rat groups (n = 8) were tested: (1) a control group (orange juice, for 7 weeks); (2) the CsA group (5 mg/kg/d for 7 weeks); (3) the Is-5-Mn group (150 mg/kg/d, twice a day for 7 weeks); (4) the prevention group (Is-5-Mn + CsA) treated for 2 weeks with Is-5-Mn only and thereafter with both drugs for 7 weeks; (5) the curative group (CsA + Is-5-Mn) beginning 7 weeks after CsA and following thereafter with both drugs for 5 weeks. Blood pressure, lipid profile, vascular lesion, platelet aggregation and morphology, and platelet thromboxane A2/vascular prostacyclin equilibrium were evaluated. Is-5-Mn + CsA therapy prevented (systolic blood pressure [SBP]: 114.3 ± 1.9 mm Hg, P < .001; diastolic blood pressure [DBP]: 97.0 ± 3.3 mm Hg, P < .001) the CsA-induced HT (SBP: 146.2 ± 4.5 mm Hg, P < .001; DBP: 124.9 ± 4.5 mm Hg, P < .001 vs control: SBP: 111.6 ± 0.7 mm Hg; DBP: 94.6 ± 1.0 mm Hg), as well as the vascular lesion and the platelet morphofunctional disturbances. The curative group did not show attenuated CsA-induced BP increase; it showed further enhancement of the HT effect (SBP: 159.7 ± 5.5 mm Hg, P < .05; DBP: 132.8 ± 2.8 mm Hg), as well as worsened vascular lesions and platelet function, namely a disruption in the TXA2/PGI2 equilibrium. Our data suggested that Is-5-Mn therapy may be a valid choice to prevent the morphofunctional changes associated with CsA-induced HT, when used as a preventive therapy. A careful evaluation of the impact of nitrate therapy should be considered, particularly the negative effect on cardiovascular hemodynamics, when considering its use after previous CsA disturbances have been established.en_US
dc.description.urihttp://www.sciencedirect.com/science/article/B6VJ0-4PYHTPY-D/1/98d9093de8c6087fd26509f72f5803f7en_US
dc.format.mimetypeaplication/PDFen
dc.language.isoengeng
dc.rightsopenAccesseng
dc.titleDual Effect of Nitrate Therapy for Cyclosporine-Induced Hypertension on Vascular and Platelet Morphofunctional Markers; An Animal Modelen_US
dc.typearticleen_US
dc.identifier.doi10.1016/j.transproceed.2007.07.029-
item.fulltextCom Texto completo-
item.grantfulltextopen-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairetypearticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.researchunitCNC - Center for Neuroscience and Cell Biology-
crisitem.author.researchunitCNC - Center for Neuroscience and Cell Biology-
crisitem.author.researchunitCNC - Center for Neuroscience and Cell Biology-
crisitem.author.orcid0000-0003-3401-9554-
crisitem.author.orcid0000-0002-9105-9619-
crisitem.author.orcid0000-0002-2601-0923-
Aparece nas coleções:FMUC Medicina - Artigos em Revistas Internacionais
Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato
file888213d6346a42b29f1720c0df2ab748.pdf618.13 kBAdobe PDFVer/Abrir
Mostrar registo em formato simples

Google ScholarTM

Verificar

Altmetric

Altmetric


Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.